Pathogenic models of Alzheimer’s disease emphasize a precipitating role of Aβ that leads to tau pathology and subsequent neurodegeneration6; however, we found that tau pathology did not appear to exert a direct effect on neurodegeneration until elevated by both cerebrovascular disease and astrocytosis. This evidence concerns the gene MAPT and cerebrovascular disorder.